GENESIS Biomed participated in the strategic development of AptaTargets, which has licensed its drug ApTOLL to Merck
...
30 October, 2025
Aortyx's pre-clinica...
ADmit Therapeutics c...
Madrid region is liv...
Having a solid scien...
ITEMAS has designed ...